Certolizumab pegol for the treatment of patients with moderate-to-severe chronic plaque psoriasis: Pooled analysis of week 16 data from 3 randomized controlled trials
Journal of the European Academy of Dermatology and Venereology | Sep 28, 2018
Journal of the European Academy of Dermatology and Venereology | Sep 28, 2018